- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 2 x H4B: 5,6,7,8-TETRAHYDROBIOPTERIN(Non-covalent)
H4B.2: 12 residues within 4Å:- Chain A: S.38, M.40, R.300, V.381, W.382
- Chain B: W.380, F.395, H.396, Q.397, E.398
- Ligands: HEM.1, JI5.3
8 PLIP interactions:7 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:R.300, A:V.381, A:W.382
- Water bridges: A:S.38, A:W.382
- pi-Stacking: A:W.382, A:W.382
- Hydrophobic interactions: B:E.398
H4B.7: 12 residues within 4Å:- Chain A: W.380, F.395, H.396, Q.397, E.398
- Chain B: S.38, M.40, R.300, V.381, W.382
- Ligands: HEM.6, JI5.8
8 PLIP interactions:7 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:R.300, B:V.381, B:W.382
- Water bridges: B:R.300, B:R.300
- pi-Stacking: B:W.382, B:W.382
- Hydrophobic interactions: A:E.398
- 2 x JI5: N-{(3R,4R)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-[2-(3-fluorophenyl)ethyl]ethane-1,2-diamine(Non-covalent)
JI5.3: 16 residues within 4Å:- Chain A: M.40, L.41, R.118, Q.182, P.269, V.271, F.288, S.289, G.290, W.291, E.296, W.382, Y.410
- Chain B: W.10
- Ligands: HEM.1, H4B.2
5 PLIP interactions:4 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:P.269, A:Y.410, A:Y.410, B:W.10
- Hydrogen bonds: A:R.118
JI5.8: 16 residues within 4Å:- Chain A: W.10
- Chain B: M.40, L.41, R.118, Q.182, P.269, V.271, F.288, S.289, G.290, W.291, E.296, W.382, Y.410
- Ligands: HEM.6, H4B.7
8 PLIP interactions:7 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:L.41, B:P.269, B:V.271, B:Y.410, B:Y.410, A:W.10
- Hydrogen bonds: B:R.118
- Water bridges: B:Q.182
- 2 x ACT: ACETATE ION(Non-functional Binders)
ACT.4: 7 residues within 4Å:- Chain A: G.121, I.123, Q.124, W.291, V.353, S.361
- Ligands: HEM.1
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:Q.124, A:W.291
- Hydrogen bonds: A:S.361, A:S.361
ACT.9: 4 residues within 4Å:- Chain B: G.121, W.291, V.353
- Ligands: HEM.6
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:S.361, B:S.361
- Water bridges: B:Q.124
- 1 x ZN: ZINC ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Delker, S.L. et al., Unexpected binding modes of nitric oxide synthase inhibitors effective in the prevention of a cerebral palsy phenotype in an animal model. J.Am.Chem.Soc. (2010)
- Release Date
- 2010-05-05
- Peptides
- Nitric oxide synthase, brain: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 2 x H4B: 5,6,7,8-TETRAHYDROBIOPTERIN(Non-covalent)
- 2 x JI5: N-{(3R,4R)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-[2-(3-fluorophenyl)ethyl]ethane-1,2-diamine(Non-covalent)
- 2 x ACT: ACETATE ION(Non-functional Binders)
- 1 x ZN: ZINC ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Delker, S.L. et al., Unexpected binding modes of nitric oxide synthase inhibitors effective in the prevention of a cerebral palsy phenotype in an animal model. J.Am.Chem.Soc. (2010)
- Release Date
- 2010-05-05
- Peptides
- Nitric oxide synthase, brain: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B